Cargando…
Modification of EBV-Associated Pathologies and Immune Control by Coinfections
The oncogenic Epstein–Barr virus (EBV) persistently infects more than 95% of the human adult population. Even so it can readily transform human B cells after infection in vitro, it only rarely causes tumors in patients. A substantial proportion of the 1% of all human cancers that are associated with...
Autor principal: | Münz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581224/ https://www.ncbi.nlm.nih.gov/pubmed/34778072 http://dx.doi.org/10.3389/fonc.2021.756480 |
Ejemplares similares
-
Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice
por: Schuhmachers, Patrick, et al.
Publicado: (2021) -
The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023) -
Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
por: Alberti, Andrea, et al.
Publicado: (2023) -
The Role of Coinfections in the EBV–Host Broken Equilibrium
por: Sánchez-Ponce, Yessica, et al.
Publicado: (2021) -
SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)